With Regeneron's recent deal, all 17 targeted pharmaceutical giants are now part of the TrumpRx program. Learn how it works ...
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already ...
Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to ...
The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.
Regeneron agreed to reduce prices for its current and future medications sold to Medicaid, and to lower the price of its ...
Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump ...
Find the latest prescription drugs news from Fast company. See related business and technology articles, photos, slideshows ...
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal ...
Today, Senator Jim Banks (R-Ind.) sent a letter to the Federal Trade Commission Chairman, Andrew Ferguson, urging the ...
The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best Japanese stocks to buy right now. On April 6, Denali ...